HOME >> MEDICINE >> NEWS
IgG treatment during pregnancy reduces severity of rare, recurring liver condition in newborns

CHICAGO --- Treatment with high-dose immunoglobulin G (IgG) during pregnancy lessens the severity of hemochromatosis (NH), a rare, devastating gestational disease with abnormal iron accumulation in the liver and severe liver injury that almost always results in fetal death or acute liver failure in newborns.

In an article in the Nov. 6 issue of The Lancet, researchers Peter F. Whitington, M.D., and Judith U. Hibbard, M.D., described the effectiveness of treating mothers with IgG in reducing liver injury in babies with recurrent NH.

Whitington, a noted authority on liver disease, is professor of pediatrics at Northwestern University Feinberg School of Medicine, Children's Memorial Hospital. Hibbard is professor of maternal-fetal medicine, University of Illinois Chicago and held a similar position at the Pritzker School of Medicine, University of Chicago, during the course of the study.

One of the most devastating aspects of NH to affected families is that after a woman has had one baby with the disorder, her risk for recurrence of NH in another child is 80 percent. A woman may have unaffected children before having the first one with NH. After that, most or all pregnancies end with fetal death or a child born with NH.

Currently, there is no test to determine if a pregnancy will be affected, and there is no effective approach to prenatal diagnosis of NH. The best advice available to date for such women is to avoid pregnancy.

Until now, the cause of NH has been unknown. Whitington hypothesized that it is an alloimmune disease based on its unusual pattern of recurrence, which is similar to the known alloimmune diseases hydrops fetalis due to Rh incompatibility and neonatal alloimmune thrombocytopenia.

Treatment with IgG has been found effective in the treatment of these alloimmune blood disorders, so Whitington proposed its use in NH.

The positive results of the current study provide support for the th
'"/>

Contact: Elizabeth Crown or Kathleen Ellis
e-crown@northwestern.edu
312-503-8928
Northwestern University
9-Nov-2004


Page: 1 2

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Chronic pain treatments more effective when taken together, new study shows
3. Brain activity prior to treatment flags vulnerability to antidepressant side effects
4. Cultural and social factors influence prostate cancer treatment
5. Research offers hope of new treatments for liver damage
6. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
7. Stanford patient is first to test new treatment for peripheral arterial disease
8. Scientist works on innovative treatments for brain tumors
9. Blacks less likely to get expensive, newer heart treatments
10. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
11. Study examines lessons learned at Africas first public antiretroviral treatment clinic

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 09, 2019 , ... Leading healthcare ... Association of American Cancer Institutes – Clinical Research Innovation (AACI-CRI) annual meeting, held ... management and data analysis. As the leading provider of clinical research technology solutions, ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... in medical marketing and communications. Covering everything from multinational holding companies to five-person ... landscape. , The 2019 version of the Agency 100 contains a full profile ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... tracking technology, today announced a validated integration between the Midmark real-time locating system ... enhancing Rauland’s nurse call platform with location data since 1997 and is implemented ...
(Date:7/9/2019)... Mass. (PRWEB) , ... July 09, 2019 , ... ... components worldwide and the largest authorized distributor for JAE Electronics in North America, ... interconnect products. , The new connectors feature a 0.5mm contact pitch and 2.5mm ...
(Date:7/9/2019)... ... ... Fonolo , the leader in cloud-based call-back solutions for the contact center, ... Prepare Your Call Center for Seasonal Call Spikes: Healthcare Edition . The new publication ... of year: Open enrollment. , Open enrollment is one of the busiest and most ...
Breaking Medicine News(10 mins):
(Date:7/10/2019)... ... 10, 2019 , ... Birk Manufacturing has announced that the company will be ... 2019, the largest exhibition for the global microelectronics industry in North America. The event ... 11, 2019. Birk Manufacturing will be showcasing at booth #152. , At the ...
(Date:7/9/2019)... ... July 10, 2019 , ... ... workshop presented by Cerulean Associates LLC and FDAnews**, Oct. 21-22, 2019, Doubletree by ... Early Bird Savings: Register by Sept. 23 and Save $200 , FDA gives ...
(Date:7/9/2019)... ... July 09, 2019 , ... DHL Global Forwarding, the air ... have released a joint report on the logistical challenges and opportunities posed by ... Partnerships: The Path to Personalized Medicine in Latin America”, the report provides a ...
Breaking Medicine Technology:
Cached News: